HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average

Autor:	M Labban, P Mali, R Jao, P Patel
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S473-S474
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.04.966
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d76d8dee1f6133f221843b6e8c252435 https://doi.org/10.1016/j.jval.2022.04.966 Zobrazit plný text záznamu Full Text from ScienceDirect